483 Sunovion Pharmaceuticals May 2013

483 Sunovion Pharmaceuticals May 2013

Kent Conforti FDA, Matthew Watson FDA$119.00 - Available Now

FDA investigators audited the Sunovion Pharmaceuticals - Marlborough, MA, United States facility and issued inspectional observations (via FDA 483) on 24 May 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 24 May 2013
  • Location: Marlborough, United States
  • FEI: 1222021
Add To Cart